Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey

Urethra-sparing is a promising technique for the mitigation of urinary toxicity in prostate cancer patients undergoing EBRT, particularly recommended for ultra-hypofractionation and reirradiation with SBRT. The lack of consensus on specific urethral dose constraints and optimal sparing techniques underscores the need for further research to standardize practices in this field.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2024-12-30
DOI
https://doi.org/10.1016/j.ctro.2024.100907
Citations
6
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey

Pierre Blanchard, Filippo Alongi, Jennifer Le Guévelou, Matthias Gückenberger et al.
6 citations
Clinical and Translational Radiation Oncology
Prostate Cancer Diagnosis and Treatment
2.51
article

Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey

Pierre Blanchard, Filippo Alongi, Jennifer Le Guévelou, Matthias Gückenberger, Paul Sargos, Thomas Zilli, Dominique Pasquier, Robert Timothy Dess, Alison Tree, Stéphane Supiot, Andrew Loblaw, Mohamed Shelan, Barbara Alicja Jereczek‐Fossa, Vedang Murthy, A. Bruynzeel, O. Chapet, Amar U. Kishan, Piet Ost, Shankar Siva, Alejandro Berlín, Stefano Arcangeli, Alan Dal Pra, Costantinos Zamboglou
article en
6 citations

Abstract

Urethra-sparing is a promising technique for the mitigation of urinary toxicity in prostate cancer patients undergoing EBRT, particularly recommended for ultra-hypofractionation and reirradiation with SBRT. The lack of consensus on specific urethral dose constraints and optimal sparing techniques underscores the need for further research to standardize practices in this field.

Clinical and Translational Radiation OncologyVol. 51
Université Claude Bernard Lyon 1 (FR), Ontario Institute for Cancer Research (CA), University of Geneva (CH), University of Bern (CH), Centre National de la Recherche Scientifique (FR), Royal Marsden NHS Foundation Trust (GB), Institute of Cancer Research (GB), University of California, Los Angeles (US), University of Toronto (CA), University of Milan (IT), Homi Bhabha National Institute (IN), European University Cyprus (CY), University of Zurich (CH), Université de Lille (FR), Université Paris-Saclay (FR), University of Michigan (US), Tata Memorial Hospital (IN), Peter MacCallum Cancer Centre (AU), University Hospital of Bern (CH), University Medical Center Freiburg (DE), Institut Gustave Roussy (FR), Princess Margaret Cancer Centre (CA), Ghent University (BE), University of Cyprus (CY), Institute of Cancer Research (CA), Centre de Radiothérapie Bayard (FR), University Hospital of Zurich (CH), Institute of Oncology Research (CH), Ospedale Sacro Cuore Don Calabria (IT), Laboratoire Traitement du Signal et de l'Image (FR), Institut de Cancérologie de l'Ouest (FR), Azienda Ospedaliera San Gerardo (IT), Centre Eugène Marquis (FR), Centre Oscar Lambret (FR), Institut Bergonié (FR), Iridium Kankernetwerk (BE), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Sylvester Comprehensive Cancer Center (US), Advanced Centre for Treatment, Research and Education in Cancer (IN), Unité en Sciences Biologiques et Biotechnologies de Nantes (FR), Università della Svizzera italiana (CH), European Institute of Oncology (IT), University of Milano-Bicocca (IT), University of Brescia (IT), Vrije Universiteit Amsterdam (NL), Nantes Université (FR)
U.S. Department of Defense, Varian Medical Systems, Boston Scientific Corporation, Royal Marsden NHS Foundation Trust, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, National Institutes of Health
Openalex Percentile: Top 10%
Prostate Cancer Diagnosis and Treatment
2.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.